• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. PDS II POLYDIOXANONE SUTURE UNKNOWN PRODUCT; SUTURE, SURGICAL, ABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. PDS II POLYDIOXANONE SUTURE UNKNOWN PRODUCT; SUTURE, SURGICAL, ABSORBABLE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Post Operative Wound Infection (2446)
Event Date 01/05/2021
Event Type  Injury  
Event Description
Title: robotic complete mesocolic excision (cme) is a safe and feasible option for right colonic cancers: short and midterm results from a single-centre experience.The aim of this study is to describe the results of a standardised technique for complete mesocolic excision surgery for colon cancer with the use of davinci robotic platform.Between january 2015 and september 2019, 77 patients undergoing standardised robotic complete mesocolic excision technique with superior mesenteric vein first approach were included in the study.There were 34 males and 43 females with a median age of 69 (34¿89) years.During the procedure, common enterotomy (stapler ends) is closed with two-layer vicryl 3/0 stitch (ethicon).The specimen is extracted through suprapubic pfannenstiel incision.A layered closure is performed with pds (ethicon) and monocryl (ethicon) sutures.Complications include small bowel injury (n=1), small bowel obstruction (n=1), wound infection (n=3), ileus (n=3), and abdominal pain (n=1).In conclusion, robotic complete mesocolic excision is feasible, effective and safe.Good oncological results and improved survival are seen in this cohort of patients with a standardised approach to robotic complete mesocolic excision.
 
Manufacturer Narrative
(b)(4).Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Does the surgeon believe that any of the ethicon products involved caused and/or contributed to the post-operative complications described in the article? does the surgeon believe there was any deficiency with any of the ethicon products used in this procedure? if so, please provide details.Were the cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number.Patient demographics? this report is related to a journal article; therefore, no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.(b)(4).The single complaint was reported with multiple events.There are no additional details regarding the additional events.Related events captured via / events were submitted via 2210968-2022-03561 and 2210968-2022-03563.Citation: surgical endoscopy (2021) 35:6873¿6881, https://doi.Org/10.1007/s00464-020-08194-z.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PDS II POLYDIOXANONE SUTURE UNKNOWN PRODUCT
Type of Device
SUTURE, SURGICAL, ABSORBABLE
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
MDR Report Key14349605
MDR Text Key291964648
Report Number2210968-2022-03562
Device Sequence Number1
Product Code NEW
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
N18331
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,User Facility
Reporter Occupation Other
Type of Report Initial
Report Date 05/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/10/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received04/28/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-